National Consumers League Statement on FTC Suit Against Live Nation and Ticketmaster

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – The National Consumers League (NCL) today welcomed the announcement that the Federal Trade Commission (FTC) and a bipartisan group of state attorneys general have sued Live Nation and Ticketmaster.  The complaint alleges that Live Nation and its Ticketmaster subsidiary rigged the system with deceptive pricing and shady broker deals, raking in hundreds of millions while sticking fans with billions in bogus fees and inflated prices.  

The following statement is attributable to John Breyault, Vice President of Public Policy, Telecommunications, and Fraud, National Consumers League: 

“NCL applauds the FTC and state attorneys general for bringing this landmark action against Live Nation and Ticketmaster. The allegations laid out by the FTC make clear what NCL has long argued: far from being an innocent victim of ticket resale, Live Nation profits from it immensely. By working hand-in-glove with ticket brokers to circumvent ticket limits and then reaping billions in fees on the resale market, Live Nation has sought to corner the secondary ticketing market just as it has monopolized the rest of the live events industry.” 

“For years, consumers and artists alike have paid the price for this anticompetitive and deceptive conduct—through hidden fees, inflated resale prices, and diminished trust in the live event marketplace. Today’s action is a vital step toward holding Live Nation accountable, restoring fairness, and ensuring that fans, not monopolists, are the ones who come first in live entertainment. It also underscores the urgent need for Congress to pass the bipartisan TICKET Act (H.R. 1402/S. 281), which would codify much-needed transparency and consumer protections into law, ensuring lasting reform of a market long tilted against fans.” 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org. 

Crackdown on Deceptive Weight Loss Drug Ads Marks Victory for Consumers

/in , , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – Justice delayed was justice denied to millions of Americans who have been exposed to a flood of deceptive advertising about the safety of the same weight loss drugs that the Food and Drug Administration warns are not approved and “could be risky for patients.”  Now, FDA is standing up for consumers by sending 100 cease-and-desist letters that tell online sellers of compounded GLP-1 drugs that it is a breach of FDA regulation to tout the benefits of the weight-loss drugs without any mention of side effects and to stop this “false or misleading” marketing.  

“Americans need a cop on the beat to protect them from the rampant disinformation now circulating online that causes consumers to tune out the advice of the FDA and leading medical societies and opt for drugs that may cause harm or could be fakes, says Nancy Glick, Director of Food and Nutrition Policy. The National Consumers League welcomes FDA’s commitment to monitor the content and claims of companies promoting GLP-1 weight loss medicines and other prescription drugs and to enforce prescription drug advertising regulations aggressively. 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

NCL Applauds Introduction of Deceptive Downsizing Prohibition Act

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Today, Congressman Correa introduced the Deceptive Downsizing Prohibition Act, a bill that would prevent misleading practices in product packaging, including undisclosed shrinkflation. The National Consumers League (NCL), Consumer Action, Consumer Federation of America, Consumer World, and Public Citizen have endorsed the bill.

“Healthy markets require transparency,” said NCL Vice President of Public Policy, Telecommunications, and Fraud John Breyault. “We appreciate that Congressman Correa is leading the charge on this commonsense policy. Consumers deserve to know if they will receive less product than they expect.”

The legislation would prohibit the sale of diminished product amounts without a reduction in packaging size. If businesses choose not to reduce their packaging size, they would have to clearly label on the product that the contents are reduced or face penalties under federal law.

###

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

Trump-Vance DOT Tees Up Abandonment of Airline Consumer Protection Law   

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC –   In its recently released regulatory agenda, the Trump-Vance Administration announced plans to abandon significant pieces of consumer protection law in air travel. The document previewed initiatives that include allowing airlines to use deceptive pricing and leave passengers stranded without mandatory care requirements, like food or lodging.    

While DOT has not released the full details of its proposals, many of the plans appear to violate legal mandates Congress charged DOT with executing. For example, longstanding law prohibits deceptive practices in air travel. Yet Transportation Secretary Duffy plans to remove basic price-transparency protections that enable fair marketplace competition.   

“This is the clearest signal so far that this DOT plans to ignore its public interest mission” said NCL Vice President of Public Policy, Telecommunications, and Fraud John Breyault. “Not only is this administration failing to implement long delayed protections, like those for families traveling with young children, it is preparing to claw back protections already in place for the flying public.”   

The agenda announced adverse actions to the following consumer protections:  

  • The Full Fare Advertising Rule, which requires airlines to include all mandatory charges in advertised prices.  
  • The Ancillary Fee Transparency Rule, which requires airlines to disclose common add-on fees at the beginning of the purchasing process.  
  •  The Automatic Refund Rule, which requires airlines to automatically refund consumers’ airfare in the event of a flight cancellation or the spread of serious communicable diseases.  
  • The Airline Passenger Rights Rulemaking, which would have required airlines to provide care (food and lodging) to stranded passengers and cash compensation for controllable flight disruptions.  

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

Fraud, Counterfeits, and Unsafe Doses: NCL Sounds Alarm on Compounded GLP-1 Market

/in , , /by

 Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC –  On behalf of the millions of consumers who have been lulled into believing that compounded GLP-1s are safe and effective for weight loss, the National Consumers League (NCL) appreciates the Food and Drug Administration’s updated policy statement warning that these drugs can carry significant health risks and should only be taken by patients who cannot tolerate the widely available FDA-approved GLP-1 medicines. 

Specifically, the FDA’s statement makes clear that: 

Compounded GLP-1s are unapproved products that do not undergo the FDA’s review for safety, effectiveness, and quality before they are marketed.  

Compounded GLP-1s carry significant safety risks and may cause serious adverse events, hospitalizations, and in some cases death. These adverse events are directly linked to dosing errors when patients measure and self-administer incorrect doses of the drug, and in some cases, when health care professionals miscalculate doses of the drug.  

The FDA has received 1,150 reports of adverse events related to compounded versions of semaglutide and tirzepatide as of July 31, 2025. Because federal law does not require all compounders to submit adverse reaction reports, these numbers are the tip of the iceberg in terms of harm to consumers. 

The FDA is aware of fraudulent compounded semaglutide and tirzepatide marketed in the U.S. that contain false information on the product label.  

The FDA is also aware that counterfeit GLP-1s are widely available online and may contain the wrong ingredients, contain too little, too much, or no active ingredient at all, or other harmful ingredients, and are illegal.  

Similarly, the agency is warning the public that bad actors are illegally selling directly to consumers unapproved ingredients falsely labeled “for research purposes” or “not for human consumption,” which are extremely dangerous. 

Making these concerns known is necessary to protect the public, but the National Consumers League calls on the FDA to take the next step by issuing regulations that will actually solve these problems and keep Americans safe. 

Unless the FDA acts forcefully, the tide of misleading online marketing of compounded GLP-1 drugs will continue, and the public will be faced with a “caveat emptor” approach that requires patients to fend for themselves. As a consequence, consumers will continue to choose treatments that may increase their health risks or opt for fraudulent and counterfeit drugs, including dangerous products that are falsely labeled “for research purposes” or “not for human consumption.” 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

Children Will Pay the Price for Florida’s Reckless Vaccine Decision

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC — The National Consumers League (NCL) strongly opposes Florida’s decision to weaken vaccine mandate protections, a move that endangers children and families. Vaccines are one of the most effective public health tools in history, eradicating or nearly eliminating diseases that once devastated communities. By removing mandates, Florida risks the return of preventable outbreaks—especially threatening children who are too young to be vaccinated or those who cannot receive vaccines for medical reasons. 

“Vaccines are one of the most effective public health tools in history, eradicating or nearly eliminating diseases like polio and measles that once devastated communities,” said Lisa Bercu, NCL’s Senior Director of Health Policy. “Removing vaccine mandates erodes critical protections for children, leaving them vulnerable to dangerous but preventable illnesses.  Without these safeguards, we risk seeing the return of diseases we thought were behind us.  The government has a responsibility to uphold vaccines as an essential public health safeguard.”

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

Congress, Public Interest Advocates File Amicus Fighting for the Independence of the CPSC

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC — Senator Amy Klobuchar led 25 other members of Congress in filing an amicus brief urging the Fourth Circuit Court of Appeals to preserve the independence and effectiveness of the Consumer Safety Product Commission (CSPC).  In May, the Trump Administration attempted to illegally fire Commissioners Alexander Hoehn-Saric, Richard Trumka, and Mary T. Boyle.

“The National Consumers League applauds Senator Klobuchar and her fellow amici for defending the spirit and letter of the law, decades of Supreme Court precedent, and the CPSC’s ability to carry out its lifesaving mission,” said Daniel Greene, Senior Director of Consumer Protection & Product Safety at the National Consumers League.  

The National Consumers League, Consumer Federation of America, and other leading consumer protection advocates also filed an amicus brief.

“The CPSC’s independence ensures that the agency is mission-driven, guided by experts and science, and insulated from changing political tides.  Silencing the voices of subject-matter experts with whom you politically disagree does not improve government efficiency. It just leads to more unnecessary deaths and more unnecessary injuries.”

In July, the National Consumers League led a letter signed by 100 stakeholders, calling on the administration to cease its attempt to fire the three Democratic CPSC Commissioners illegally. A copy of the letter can be found HERE

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet

CDC Guts Food Safety Net: A Dangerous Gamble with American Lives

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – In 1736, Benjamin Franklin advised the people of Philadelphia that “an ounce of prevention is worth a pound of cure.” Our famous forefather was talking about fire prevention but his words should now be directed to the Centers for Disease Control and Prevention (CDC), which recently cut its Food Diseases Active Surveillance Network (FoodNet) to track only infections from two foodborne pathogens, Salmonella and Shiga toxin–producing Escherichia coli (STEC).  

It is true that Salmonella and STET are among the top contributors to foodborne illnesses in the U.S. Yet, another six major pathogens – Campylobacter, Cyclospora, Listeria, Shigella, Vibrio, and Yersinia –also contribute to the estimated 48 million cases of foodborne illness in the US every year. And now, CDC has decided that it will be up to the states participating in FoodNet to determine if and how they will track and report illnesses from these pathogens.

It is worth remembering that the CDC created FoodNet in 1995 as a response to the 1992–1993 Jack in the Box E. coli outbreak, when over 700 people were badly sickened and four children died from eating hamburgers containing the deadly strain of Escherichia coli O157:H7 bacterium. It was a national scandal the country vowed not to repeat. “Sadly, the CDC has decided to play Russian Roulette with the health of Americans because states simply do not have the ability to coordinate information and data beyond their borders,” says Nancy Glick, Director of Food and Nutrition Policy at the National Consumers League. Therefore, the detection and information-sharing about major food pathogens will become more difficult and the spread of foodborne disease outbreaks will be more likely.

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

Purging Science from Federal Agencies is Endangering the Health of Every American 

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829  

Washington, DC – The National Consumers League (NCL) is greatly concerned about the recent upheaval at the Centers for Disease Control and Prevention (CDC), including the abrupt ousting of CDC Director Susan Monarez less than a month after she was sworn in. 

“These departures are a warning about the state of science and our public health agencies in America. Government public health experts do not seek high salaries; they are driven by an unwavering commitment to advancing public health, fostering research and development, and ensuring safe, effective, and affordable medicine grounded in science and evidence,” says Lisa Bercu, NCL’s Senior Director of Health Policy.  

“By forcing out these dedicated professionals, this administration and RFK Jr. have significantly weakened our healthcare infrastructure,” Bercu continued. “RFK Jr. is leading one of the most hostile efforts in modern U.S. history against credible science and good medicine—actions that are deeply dangerous to the health and well-being of all Americans.”   

Director Monarez was confirmed on July 29, 2025, through a narrow Senate vote and assumed leadership on July 31. Only weeks later, on or around August 27, she was removed from her position amid accusations of refusing to implement politically motivated directives.   

Additionally, at least four senior CDC officials—Dr. Debra Houry, Dr. Demetre Daskalakis, Dr. Daniel Jernigan, and Dr. Jennifer Layden resigned in protest, decrying the “weaponization of public health” and politicization of agency leadership. These events signal a grave erosion of science-first governance at one of our nation’s foremost public health institutions. 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.    

NCL Sends Letter to Senate HELP Committee on Lowering Healthcare Costs

/in , , /by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – On July 31, 2025, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the rising cost of healthcare and the urgent need for patient-focused reform. Lawmakers and expert witnesses discussed challenges with employer-sponsored insurance, the lack of price transparency, and the profit-driven nature of the U.S. healthcare system.

In response, the National Consumers League submitted a letter urging the Committee to take swift, bipartisan action to address medical debt, pharmacy benefit manager (PBM) reform, oversight of the 340B program, and healthcare price transparency. These are essential steps to protect consumers and ensure that our healthcare system works for everyone. A copy of the letter can be found HERE. 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.